Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Alcon
ALC
Market cap
$39B
Overview
Fund Trends
Analyst Outlook
Journalist POV
79.94
USD
+0.20
0.25%
At close
Updated
Apr 14, 4:00 PM EDT
Pre-market
After hours
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
0.25%
5 days
2.24%
1 month
2.76%
3 months
-0.21%
6 months
7.91%
Year to date
3.02%
1 year
-11.75%
5 years
9.07%
10 years
37.73%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
58.3%
Negative
Positive
Neutral
Negative
Negative
Zacks Investment Research
13 hours ago
Are Medical Stocks Lagging Alcon (ALC) This Year?
Here is how Alcon (ALC) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.
Neutral
Seeking Alpha
5 days ago
STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid
STAAR Surgical Company has seen a dramatic valuation reset, now trading at a $1bn market cap after failed acquisition talks and underwhelming US growth. Q1 2026 net sales are expected to exceed $90m, driven by a strong rebound in China and signaling potential for record annual revenues. Despite operational challenges and competitive pressures, STAA's proprietary Collamer lens and expanded US indications provide incremental growth opportunities.
Positive
Zacks Investment Research
6 days ago
Alcon Stock Gains Following the Launch of Clareon TruPlus at ASCRS
ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.
Neutral
Business Wire
8 days ago
Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026
FORT WORTH, Texas--(BUSINESS WIRE)--Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026.
Neutral
Business Wire
12 days ago
Alcon Publishes Agenda for 2026 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2026 Annual General Meeting.
Neutral
Business Wire
12 days ago
Alcon Publishes Agenda for 2026 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2026 Annual General Meeting.
Positive
Seeking Alpha
28 days ago
Alcon Buy Rating Reaffirmed, Despite Failed STAAR Merger, As Eyecare Portfolio Leads
Alcon is reaffirmed as a buy, supported by robust macro demand in eyecare and a strong product pipeline despite abandoning the STAAR Surgical acquisition. ALC demonstrates potential resilience versus market shocks, with favorable balance sheet risk and positive EPS forecasts for FY26. While ALC lags peers in some profitability metrics and offers only an annual 0.43% dividend, its low payout ratio and dividend growth provide some support to the dividend case.
Neutral
Business Wire
29 days ago
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
GENEVA--(BUSINESS WIRE)--Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement.
Positive
Zacks Investment Research
1 month ago
5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside
ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.
Neutral
GlobeNewsWire
1 month ago
Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education
New English and Spanish editions of Understanding and Living with Glaucoma and first-ever Spanish audiobook aim to reach high-risk Hispanic communities Resources will be available during Glaucoma Awareness Week beginning March 9th SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today announced a new partnership with Alcon, the global leader in eye care, to expand access to trusted, patient-centered glaucoma education for Spanish-speaking patients and families in the United States. Through Alcon's support, GRF will release an updated English and Spanish editions of its widely used “Understanding and Living with Glaucoma” booklet and introduce the first-ever Spanish audiobook version of this essential resource.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close